Related Experiment Video
Updated: Jul 3, 2026
07:07
Analysis of Learning and Memory Ability in an Alzheimer's Disease Mouse Model using the Morris Water Maze
Published on: October 29, 2019
A novel derivative of xanomeline improved memory function in aged mice
Yi-Hui Cui1, Wen Si, Liang Yin
1Shanghai Institute of Brain Functional Genomics, the Key Laboratories of Ministry of Education of China and Shanghai Municipality, East China Normal University, Shanghai, China.
Neuroscience Bulletin
|August 1, 2008
Summary
A new M1 agonist, EUK1001, shows reduced toxicity and enhances cognitive function in aged mice. This compound improved memory and synaptic plasticity, suggesting potential for treating age-related cognitive decline.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Age-related cognitive deficits are a growing concern.
- M1 agonists are being investigated for cognitive enhancement.
- Xanomeline is a known M1 agonist with some limitations.
Purpose of the Study:
- To evaluate the safety and efficacy of EUK1001, a novel xanomeline-derived M1 agonist.
- To assess the acute toxicity of EUK1001.
- To investigate the effects of EUK1001 on synaptic plasticity and cognitive function in aged mice.
Main Methods:
- Median lethal dose (LD50) determination via oral and intraperitoneal administration in aged mice.
- Novel object recognition task to assess recognition memory.
- In vitro electrophysiology to evaluate hippocampal synaptic plasticity.
Main Results:
- EUK1001 demonstrated lower toxicity compared to xanomeline.
- Aged mice treated with EUK1001 showed improved performance in the novel object recognition test.
- 1 micromol/L EUK1001 directly induced long-term potentiation in hippocampal slices.
Conclusions:
- EUK1001 effectively improves age-related cognitive deficits.
- The compound shows promise as a therapeutic agent for cognitive impairment.
